BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.20.01788
PubMed Identifier: 32730185
Publication URI: http://europepmc.org/abstract/MED/32730185
Type: Journal Article/Review
Volume: 38
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 30
ISSN: 0732-183X